This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Endocrine diseases | |
|---|---|
| Name | Endocrine diseases |
| Field | Endocrinology |
| Causes | Various endocrine gland dysfunctions |
Endocrine diseases are disorders arising from dysfunction of hormone-producing glands, affecting homeostasis, growth, metabolism, reproduction, and stress responses. They encompass a wide array of conditions involving the thyroid gland, pituitary gland, adrenal gland, pancreas, and gonadal organs, and intersect with clinical specialties such as internal medicine, pediatrics, obstetrics and gynaecology, and geriatric medicine. Diagnosis and management often require integration of clinical assessment, biochemical testing, imaging, and sometimes genetic analysis, and they have significant implications for public health, health policy, and biomedical research.
Endocrine diseases include disorders of hormone excess, deficiency, or resistance that affect systems from growth and development to energy balance and reproduction. Major clinical syndromes include thyroid disorders (e.g., Graves disease, Hashimoto's thyroiditis), glucose homeostasis disorders (e.g., diabetes mellitus types 1 and 2), adrenal disorders (e.g., Cushing's syndrome, Addison's disease), pituitary disorders (e.g., acromegaly, hypopituitarism), and gonadal disorders (e.g., polycystic ovary syndrome, hypogonadism). Management spans acute care in settings such as emergency department and chronic care in contexts like primary care and specialist clinics, with intersections with public health programs such as those led by World Health Organization and national health agencies.
Endocrine conditions may be classified by affected gland, hormone pathway, or etiology. By gland: thyroid diseases, pituitary diseases, adrenal diseases, pancreatic islet disorders, and gonadal disorders. By mechanism: hypersecretion (e.g., pheochromocytoma), hyposecretion (e.g., insulin deficiency), hormone resistance (e.g., androgen insensitivity syndrome), and neoplastic processes (e.g., multiple endocrine neoplasia syndromes). Genetic endocrine disorders include congenital syndromes described in resources from institutions such as National Institutes of Health and academic centers like Mayo Clinic and Johns Hopkins Hospital; autoimmune endocrine diseases often have associations with conditions cataloged by societies like the Endocrine Society.
Etiologies encompass autoimmune destruction, genetic mutations, neoplasia, infection, iatrogenic injury (surgery, radiation, pharmacologic), and metabolic or vascular insults. Autoimmune mechanisms underlie conditions like Type 1 diabetes mellitus and Hashimoto's thyroiditis; genetic mutations in genes such as those implicated in MEN1 or RET proto-oncogene drive hereditary neoplasia. Neoplastic endocrine tumors (e.g., insulinoma, medullary thyroid carcinoma) may produce ectopic hormones or compress adjacent structures. Environmental and lifestyle factors link to disorders such as type 2 diabetes mellitus and obesity, with public health frameworks examined by agencies like Centers for Disease Control and Prevention and research programs at universities including Harvard University and University of Oxford.
Diagnosis integrates clinical evaluation, biochemical assays, dynamic endocrine testing, imaging, and genetic testing. Laboratory modalities include serum hormone measurements, autoantibody panels (e.g., anti-thyroid peroxidase), and metabolic markers used in protocols from institutions like Cleveland Clinic and Mayo Clinic. Imaging modalities—ultrasound, computed tomography, magnetic resonance imaging, and nuclear medicine scans—are deployed in alignment with guidelines from professional bodies such as American Thyroid Association and European Society of Endocrinology. Genetic diagnosis may involve sequencing approaches practiced in centers like Broad Institute and Wellcome Sanger Institute for hereditary syndromes.
Therapies include hormone replacement (e.g., levothyroxine), pharmacologic suppression (e.g., antithyroid drugs), targeted oncology therapies (e.g., tyrosine kinase inhibitors for certain thyroid cancers), surgical interventions (thyroidectomy, adrenalectomy, pancreatectomy, pituitary surgery with approaches developed at Karolinska Institutet and Massachusetts General Hospital), and minimally invasive or image-guided procedures from interventional radiology services at hospitals such as Guy's and St Thomas' NHS Foundation Trust. Chronic disease management integrates lifestyle interventions promoted by organizations like American Diabetes Association and World Health Organization for metabolic disorders. Emerging treatments include gene therapy, monoclonal antibodies, peptide receptor radionuclide therapy used in neuroendocrine tumors, and precision medicine initiatives funded by organizations such as National Cancer Institute.
Endocrine disorders contribute substantially to global morbidity and mortality, with conditions such as diabetes mellitus and thyroid diseases prevalent across regions studied by WHO and national health surveys like the National Health and Nutrition Examination Survey. Incidence and prevalence vary by demographic factors and social determinants addressed in reports from bodies such as United Nations and World Bank. Screening programs (e.g., neonatal screening for congenital hypothyroidism), vaccination and public health initiatives, and chronic care frameworks influence disease burden and are topics of policy discussion in forums including the G20 and regional health ministries.
Historical milestones include the discovery of insulin by researchers associated with University of Toronto and the elucidation of thyroid hormone biology with contributions from laboratories at University of Cambridge and Oslo University Hospital. The field evolved through surgical advances pioneered at centers like Johns Hopkins Hospital and pharmacologic breakthroughs associated with pharmaceutical firms and regulatory agencies such as Food and Drug Administration. Current research directions emphasize molecular endocrinology, endocrine disruptors investigated by groups at Environmental Protection Agency, genomics and precision medicine spearheaded by institutions like Stanford University and Broad Institute, and global health implementation research coordinated by World Health Organization. Ongoing clinical trials and translational research aim to refine diagnostics, personalize therapies, and address disparities documented by organizations including Global Fund and World Bank.